In breast cancer, numerous variants in genes encoding ATP synthase‐binding cassette (ABC) transporters, cytochrome P450 enzymes, glutathione S‐transferases, HER2, and others have been associated with therapy resistance [202]. Here, ERBB2 is linked to breast cancer.